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Abstract
Protective effects of clinically used drugs against adriamycin (ADM)-induced toxicity were
studied in ICR mice. The control mice, which were administered 15 mg/kg of ADM twice, sur-
vived 7.48 +/- 1.99 days (mean +/- S.D.). The survival times of mice treated with the following
drugs, expressed as a percent of that of the control group, were 293.6% for coenzyme Q10 (Co
Q10, 2 mg/kg), 402.2% for dextran sulfate (MDS, 300 mg/kg), 121.6% for flavin adenine dinu-
cleotide (20 mg/kg), 236.3% for adenosine triphosphate disodium (50 mg/kg), 213.7% for reduced
glutathione (100 mg/kg), 121.6% for phytonadione (50 mg/kg), 155.2% for inositol nicotinate
(Ino-N, 500 mg/kg), 335.5% for nicomol (1000 mg/kg), 157.5% for nicardipine (10 mg/kg) and
123.3% for dipyridamol (50 mg/kg). Anti-hyperlipemic agents such as MDS, nicomol, Ino-N and
Co Q10 strongly protected against the ADM-induced toxicity, and the mice administered these
drugs lived significantly longer than the control mice. The mechanism of the protective effect was
discussed.
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